NY could allow marijuana at movie theaters; IA & MN psilocybin bills; Study: Schedule I complicates marijuana research; TX & FL hemp restrictions
Subscribe to receive Marijuana Moment’s newsletter in your inbox every weekday morning. It’s the best way to make sure you know which cannabis stories are shaping the day.
Your support makes Marijuana Moment possible…
Free to read (but not free to produce)! We’re proud of our newsletter and the reporting we publish at Marijuana Moment, and we’re happy to provide it for free. But it takes a lot of work and resources to make this happen.
If you value Marijuana Moment, invest in our success on Patreon so we can expand our coverage and more readers can benefit: https://www.patreon.com/marijuanamoment
/ TOP THINGS TO KNOW
President Donald Trump’s White House said local marijuana reform in Washington, D.C. is a “failed” policy that “opened the door to disorder.”
A New York Office of Cannabis Management spokesperson said movie theaters could sell marijuana and allow use during films if they obtain event permits or consumption lounge licenses that regulators will offer in the future.
The Iowa House Ways and Means Committee unanimously approved a bill to create a state-regulated therapeutic psilocybin program for up to 5,000 people with PTSD.
Minnesota representatives filed a bill to legalize the use and cultivation of psilocybin for medical purposes, with provisions modeled on “the successes and lessons of Minnesota’s medical cannabis program.”
A new study on government support for marijuana research in states that have enacted legalization says that ongoing federal prohibition makes the process “complicated” and leaves some states too “risk averse” to allocate tax dollars to back cannabis studies.
Texas Lt. Gov. Dan Patrick (R) said he will push for a special session to enact legislation to ban consumable hemp products with any amount of THC if it does not pass during the regular session.
The Florida Senate Fiscal Policy Committee approved a bill to restrict intoxicating hemp products—including banning synthetic cannabinoids like delta-8 THC and allowing only stores with liquor licenses to sell hemp-infused drinks.
Missouri lawmakers are debating how to allocate marijuana revenues that the director of the Division of Cannabis Regulation says “continue to outpace expectations.”
The Massachusetts inspector general is calling on the Cannabis Control Commission to conduct an audit following its failure to collect approximately $550,000 in licensing fees since August 2022.
/ FEDERAL
The Drug Enforcement Administration could be merged with the Bureau of Alcohol, Tobacco, Firearms and Explosives under a proposal from Deputy Attorney General Todd Blanche.
Sen. Steve Daines (R-MT) said the focus of his recent discussions with Chinese leaders was that “we currently have a drug war going on. I don’t want to see a trade war.”
Rep. Morgan Luttrell (R-TX) touted the Department of Defense backing research on the benefits of MDMA for military service members, tweeting, “This funding—driven by our work in Congress—moves us closer to giving our warfighters better treatment options beyond the same risky opioid prescriptions.”
/ STATES
Kentucky Gov. Andy Beshear (D) signed a bill to enact stricter regulations on hemp beverages.
Delaware lawmakers sent Gov. Matt Meyer (D) a bill to allow the Newark Alderman’s Court to hear cases involving marijuana offenses.
The New Jersey Assembly Oversight Committee approved legislation on cannabis industry workers’ rights and the municipal marijuana business approval process.
A Minnesota senator spoke about his legislation to alter medical cannabis rules.
A Michigan judge found that a cannabis testing company launched by former police used unapproved procedures and failed to properly document its activities.
California regulators announced a recall of marijuana products due to the presence of aspergillus and inaccurate labeling that reports more cannabinoid content than the products contain.
Oregon regulators recalled cannabis cookies due to a failure to note that they contain the allergen milk.
Massachusetts regulators approved an amended order on marijuana product testing.
Arkansas regulators rejected a request from Metrc to reconsider their decision to award a medical cannabis track and trace contact to BioTrack THC.
U.S. Virgin Islands regulators will begin accepting some cannabis license and permit applications on Monday.
Michigan regulators signed order and stipulation documents to permanently close a marijuana processing business following alleged violations.
—
Marijuana Moment is tracking hundreds of cannabis, psychedelics and drug policy bills in state legislatures and Congress this year. Patreon supporters pledging at least $25/month get access to our interactive maps, charts and hearing calendar so they don’t miss any developments.
Learn more about our marijuana bill tracker and become a supporter on Patreon to get access.
—
/ LOCAL
New York City’s top cannabis regulator stepped down.
/ INTERNATIONAL
A UK lawmaker said he thinks officials with the Office for Budget Responsibility have been “eating some form of magic mushrooms” in light of what he called “completely delusional” growth forecasts.
/ SCIENCE & HEALTH
A study “supports CBD as a potential treatment for monogenic epilepsies beyond its licensed indications, demonstrating comparable effectiveness between approved and off-label use and suggesting genetic subgroups with promising treatment responses.”
/ ADVOCACY, OPINION & ANALYSIS
The Pittsburgh Post-Gazette editorial board said legalizing marijuana “would come with some clear benefit” but it is not the answer to the state’s budget problems.
/ BUSINESS
Gold Flora Corporation filed for a voluntary receivership.
A Massachusetts judge dismissed a shareholder lawsuit against Tilray Brands Inc. and its subsidiary HEXO Corporation.
Rapid Analytics LLC is being sued by James River Insurance Co., which is seeking to avoid covering the cannabis testing lab in claims arising from the suspension of its license due to alleged violations.
/ CULTURE
Boxer Claressa Shields said she will work to change drug testing rules to prevent others from being suspended for false positives like she was.
Make sure to subscribe to get Marijuana Moment’s daily dispatch in your inbox.
Photo courtesy of Chris Wallis // Side Pocket Images.
The post Trump White House says cannabis decrim “failed” in DC (Newsletter: March 31, 2025) appeared first on Marijuana Moment.
